After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm
Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells
Stay updated with breaking news from Bar Ilan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells
Home Front Command's COVID testing facilities to close, while head of the Laboratory of Immunotherapy says the goal was to reach an 'endemic' stage of the virus when the disease is spreading at a normal or expected level
News Analysis: Challenges lie ahead as Netanyahu forms new Israeli gov't-
Caroline Glick hosts a debate between jurists Alan Dershowitz and Avi Bell about why the Israeli Supreme Court needs reforms.
Shas leader Arye Deri called the actions of the rioters "a blasphemy of God" and joined his political partners in condemning the events.